25
directly applicable to human populations, but ten or
more years' follow-up may be needed to provide
answers about some health effects, such as cancer.
This is because the interval between the time of
exposure to a cancer-causing agent and the time
tumors develop - if they do - may be many, many
years. The interpretation of epidemiological studies is
hampered by difficulties in measuring actual RF
exposure during day-to-day use of wireless phones.
Many factors affect this measurement, such as the
angle at which the phone is held, or which model of
phone is used.
What is FDA doing to find out more about the
possible health effects of wireless phone RF?
FDA is working with the U.S. National Toxicology
Program and with groups of investigators around the
world to ensure that high priority animal studies are
conducted to address important questions about the
effects of exposure to radio frequency energy (RF).
FDA has been a leading participant in the World Health
Organization international Electromagnetic Fields
(EMF) Project since its inception in 1996. An influential
result of this work has been the development of a
detailed agenda of research needs that has driven the
establishment of new research programs around the
world. The Project has also helped develop a series of
public information documents on EMF issues.
FDA and Cellular Telecommunications & Internet
Association (CTIA) have a formal Cooperative
Research and Development Agreement (CRADA) to do
research on wireless phone safety. FDA provides the
scientific oversight, obtaining input from experts in
government, industry, and academic organizations.
CTIA-funded research is conducted through contracts
to independent investigators. The initial research will
include both laboratory studies and studies of wireless
phone users. The CRADA will also include a broad
assessment of additional research needs in the
context of the latest research developments around
the world.
